Recent studies have shown that leptin (an adipocytokine) played an important role in nociceptive behavior induced by nerve injury, but the cellular mechanism of this action remains unclear. Using the wholecell patch-clamp recording from rat's spinal cord slices, we showed that superfusion of leptin onto spinal cord slices dose-dependently enhanced N-methyl-D-aspartate (NMDA) receptor-mediated currents in spinal cord lamina II neurons. At the cellular level, the effect of leptin on spinal NMDA-induced currents was mediated through the leptin receptor and the JAK2/STAT3 (but not PI3K or MAPK) pathway, as the leptin effect was abolished in leptin receptor-deficient (db/db) mice and inhibited by a JAK/STAT inhibitor. Moreover, we demonstrated in naïve rats that a single intrathecal administration of leptin enhanced spontaneous biting, scratching, and licking behavior induced by intrathecal NMDA and that repeated intrathecal administration of leptin elicited thermal hyperalgesia and mechanical allodynia, which was attenuated by the noncompetitive NMDA receptor antagonist MK-801. Intrathecal leptin also upregulated the expression of NMDA receptors and pSTAT3 within the rat's spinal cord dorsal horn, and intrathecal MK-801 attenuated this leptin effect as well. Our data demonstrate a relationship between leptin and NMDA receptor-mediated spinal neuronal excitation and its functional role in nociceptive behavior. Since leptin contributes to nociceptive behavior induced by nerve injury, the present findings suggest an important cellular link between the leptin's spinal effect and the NMDA receptor-mediated cellular mechanism of neuropathic pain. Ó
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Introduction
Pain resulting from injury or disease of the nervous system (neuropathic pain) is a debilitating chronic pain condition involving both peripheral and central mechanisms [10, 36, 64, 66] . Recent studies have shown that leptin, an adipocytokine, played a significant role in nociceptive behavior induced by nerve injury in rats [31, 35] . While the peripheral effect of leptin on neuropathic pain is mediated via macrophage stimulation [35] , its central effect is likely related to the upregulation of N-methyl-D-aspartate receptors (NMDAR) following nerve injury [31] . To date, the exact cellular mechanism of the leptin action in neuropathic pain remains unclear.
Leptin is a 16-kDa adipocytokine produced mainly by white adipose tissue and is well known for its role in metabolic regulation and obesity [1, 11, 12, 50, 68] . Several studies indicate that leptin has a broad role in the regulation of neuronal functions [2, 21] , which is believed to be mediated by a long-form leptin receptor (Ob-Rb) resulting in Janus tyrosine kinase 2 (JAK2)-mediated phosphorylation of tyrosine residues within the cytoplasmic tail of the Ob-Rb receptor [40] . This cellular effect, in turn, recruits and activates downstream signaling pathways including the signal transducers and activators of transcription factors 3 (STAT3) pathway, insulin receptor substrate proteins and its downstream phosphoinositide 3-kinase (PI3K), and/or the Ras-Raf-MAPK (mitogen-activated protein kinase) signaling cascade [3, 22] .
Recent studies have also suggested a possible functional link between leptin and NMDAR. For example, exposure to leptin enhanced NMDAR activity and modulated NMDAR-dependent longterm potentiation (LTP) in an in vitro hippocampal preparation [51] , whereas administration of leptin into the hippocampal dentate gyrus enhanced LTP in vivo [61] . Genetically obese rodents with dysfunctional leptin receptors displayed impairments in both NMDAR-dependent hippocampal long-term depression and LTP [16, 29] . Moreover, repeated leptin administration during the early stage of life altered both the short-term and long-term expression of NMDAR, synaptic proteins, and LTP in the rat's hippocampus [57] . 
